Bristol-Myers Squibb (BMY)

2020 has taken the market capitalizations of many strong companies to lows. That means there are some great options for cheap stocks to buy in January.

7 Cheap Stocks That Can’t Wait for 2021

By Bret Kenwell, InvestorPlace Contributor Dec 31, 2020

Cheap stocks have always intrigued investors because we always want a bargain. So, here are seven cheap stocks to buy now.

7 Undervalued Stocks to Buy Now

By Bret Kenwell, InvestorPlace Contributor Dec 9, 2020

Everyone is on the hunt for undervalued stocks. Keep in mind, even more highly valued stocks can be undervalued. Let's look at seven of them.

3 Cheap Dividend Stocks For High Total Returns

By Bob Ciura, Sure Dividend Dec 8, 2020

Cheap dividend stocks can generate a double dose of returns, with dividends as well as capital appreciation through a rising share price.

7 Pharmaceutical Stocks to Buy for 2021 and Beyond

By Bret Kenwell, InvestorPlace Contributor Nov 17, 2020

Pharmaceutical stocks help make the world go round. Without them, common ailments would plague our lives. With them, we can solve Covid-19.

7 Healthcare Stocks That Can Survive Massive Reform

By Tezcan Gecgil, InvestorPlace Contributor Nov 2, 2020

These seven healthcare stocks may represent robust long-term investments no matter how reforms in the sector may develop post-election.

7 Cutting-Edge Biotech Stocks for Tomorrow

By Bret Kenwell, InvestorPlace Contributor Oct 28, 2020

Biotech stocks are always going to be here, in good times and bad. Let's look at a few that are worth considering on the long side.

M&A News: MyoKardia (MYOK) Stock Soars on Bristol Myers Squibb Deal

By Nick Clarkson, Web Editor Oct 5, 2020

MyoKardia's major, $13.1 billon deal with fellow pharmaceutical company Bristol Myers Squibb sent MYOK stock soaring on Monday.

This Company is the Landlord of Life Sciences

By Neil George Aug 7, 2020

Alexandria Real Estate Equities is the largest landlord in the US for laboratories and related offices.

5 Top Stock Trades for Friday: UBER, FB, BMY, MU, TWLO

By Bret Kenwell, InvestorPlace Contributor Aug 6, 2020

Bristol-Myers Squibb, Uber, Facebook, Micron and Twilio were our top stock trades for Friday. That said, let's look at the charts now.

Bristol-Myers Squibb Earnings: BMY Stock Jumps 2% on Q2 Beats

By Nick Clarkson, Web Editor Aug 6, 2020

Bristol-Myers Squibb earnings on Thursday have BMY stock rising higher after the company beat EPS and revenue estimates from Wall Street.

Bristol-Myers Squibb Is a Dirt-Cheap Buy Before Earnings

By David Moadel, InvestorPlace Contributor Aug 4, 2020

Thanks to its Celgene acquisition, Bristol-Myers Squibb looks attractive ahead of earnings. Here's why you should buy BMY stock.

Bristol-Myers Squibb Has Great Potential Ahead of Earnings

By Mark R. Hake, CFA Aug 4, 2020

Ahead earnings, Bristol-Myers Squibb is a great value play. In fact, BMY stock is worth 30%-70% more than its current share price.

5 Healthcare Stocks for Good (Portfolio) Health

By Vince Martin, InvestorPlace Contributor Aug 3, 2020

These 5 healthcare stocks look like the sector's best, with downside protection and room for price appreciation even if the market falters.

Undervalued Bristol-Myers Squibb Stock Is Worth 50% More

By Mark R. Hake, CFA Jul 22, 2020

BMY stock looks cheap here. Bristol-Myers is a defensive value with an attractive yield, cheap valuation, and plenty of potential upside.

Bristol-Myers Squibb (BMY)

7 Pharmaceutical Stocks With Dividends in Hand

IMMP Stock: Why Is Biotech Company Immutep Rocketing Higher Today?

7 Value Stocks Ready for the Next 10 Years

3 High-Quality Health Care Companies With Recession-Proof Dividends

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Bristol-Myers Squibb (BMY)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

BMY Stock Predictions, Articles, and Bristol-Myers Squibb News

Subscriber Sign in